Öz
Tiroid nodülü foliküler hücrelerden köken alan ve radyolojik olarak tiroid parankiminden ayırt edilen lezyonlara karşılık gelmektedir. Kadınlarda daha sık görülmekte ve sıklığı yaşla birlikte artmaktadır. Yapılan USG taramalarında %20-67 tiroidde nodül saptanmaktadır. Tiroid nodüllerinin %7-15’inden karsinom gelişmektedir. Tiroid nodülü saptanan hastalardan TSH görülmeli ve Tiroid USG istenmelidir. Tiroid USG özelliklerine göre de hastalardan İİAB istenmelidir. Tiroid İİAB sonuçları Bethesda sınıflamasına göre değerlendirilmektedir. İİAB sonuçları, hastanın klinik özellikleri, USG bulguları ve moloküler testlere göre nodüle yönelik tedavi planlanmaktadır. Bu yazıda güncel literatür eşliğinde tiroid nodülüne yaklaşım ele alınmıştır.
Anahtar Kelimeler
tiroid nodülü ince iğne aspirasyon biopsisi ultrasonografi tedavi
Kaynakça
- 1. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE at al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 2016, 26:1-133.
- 2. Wong R, Farrell SG, Grossmann M: Thyroid nodules: diagnosis and management. The Medical Journal of Australia 2018, 209:92-98.
- 3. Mazzaferri EL: Management of a solitary thyroid nodule. New England Journal of Medicine 1993, 328:553-559.
- 4. Burman K, Wartofsky L: CLINICAL PRACTICE. Thyroid Nodules. The New England journal of medicine 2015, 373:2347.
- 5. Tan GH, Gharib H: Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Annals of internal medicine 1997, 126:226-231.
- 6. Fisher SB, Perrier ND: The incidental thyroid nodule. CA: a cancer journal for clinicians 2018, 68:97-105.
- 7. Paschou SΑ, Vryonidou A, Goulis DG: Thyroid nodules: Α guide to assessment, treatment and follow-up. Maturitas 2017, 96:1-9.
- 8. Burman KD, Wartofsky L: Thyroid nodules. New England Journal of Medicine 2015, 373:2347-2356.
- 9. Detweiler K, Elfenbein DM, Mayers D: Evaluation of Thyroid Nodules. Surgical Clinics 2019, 99:571-586.
- 10. Sklar C, Whitton J, Mertens A, Stovall M, Green D, Marina N i at al. : Abnormalities of the thyroid in survivors of Hodgkin’s disease: data from the Childhood Cancer Survivor Study. The Journal of Clinical Endocrinology & Metabolism 2000, 85:3227-3232.
- 11. Yang SP, Ngeow J: Familial non-medullary thyroid cancer: unraveling the genetic maze. Endocrine-related cancer 2016, 23:R577-R595.
- 12. Alfonso A, Christoudias G, Amaruddin Q, Herbsman H, Gardner B: Tracheal or esophageal compression due to benign thyroid disease. The American Journal of Surgery 1981, 142:350-354.
- 13. Gharib H, Goellner JR: Fine-needle aspiration biopsy of the thyroid: an appraisal. Annals of internal medicine 1993, 118:282-289.
- 14. Boelaert K, Horacek J, Holder R, Watkinson J, Sheppard M, Franklyn J: Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. The Journal of Clinical Endocrinology & Metabolism 2006, 91:4295-4301.
- 15. Walsh JP: Managing thyroid disease in general practice. Medical Journal of Australia 2016, 205:179-184.
- 16. Wells Jr SA, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF, at al : Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma: the American Thyroid Association Guidelines Task Force on medullary thyroid carcinoma. Thyroid 2015, 25:567-610.
- 17. Jeh S-k, Jung SL, Kim BS, Lee YS: Evaluating the degree of conformity of papillary carcinoma and follicular carcinoma to the reported ultrasonographic findings of malignant thyroid tumor. Korean journal of radiology 2007, 8:192-197.
- 18. Wilhelm S: Evaluation of thyroid incidentaloma. Surgical Clinics 2014, 94:485-497.
- 19. Shie P, Cardarelli R, Sprawls K, Fulda KG, Taur A: Systematic review: prevalence of malignant incidental thyroid nodules identified on fluorine-18 fluorodeoxyglucose positron emission tomography. Nuclear medicine communications 2009, 30:742-748.
- 20. Nishino M, Krane JF: Updates in thyroid cytology. Surgical pathology clinics 2018, 11:467-487.
- 21. Gharib H, Papini E, Garber J, Duick D, Harrell R, Hegedüs L, et al : AACE/ACE/AME task force on thyroid nodules. american association of clinical endocrinologists, american college of endocrinology, and associazione medici endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules-2016 update. Endocr Pract 2016, 22:622-639. 22. Cibas ES, Ali SZ: The 2017 Bethesda system for reporting thyroid cytopathology. Thyroid 2017, 27:1341-1346.
- 23. Shin JJ, Caragacianu D, Randolph GW: Impact of thyroid nodule size on prevalence and post‐test probability of malignancy: a systematic review. The Laryngoscope 2015, 125:263-272.
- 24. Bennedbæk FN, Hegedüs L: Treatment of recurrent thyroid cysts with ethanol: a randomized double-blind controlled trial. The Journal of Clinical Endocrinology & Metabolism 2003, 88:5773-5777.
- 25. Ito Y, Miyauchi A, Inoue H, Fukushima M, Kihara M, Higashiyama T, et al: An observational trial for papillary thyroid microcarcinoma in Japanese patients. World journal of surgery 2010, 34:28.
- 26. Mitchell J, Yip L: Decision Making in Indeterminate Thyroid Nodules and the Role of Molecular Testing. Surgical Clinics 2019.
Ayrıntılar
| Birincil Dil | Türkçe |
|---|---|
| Konular | Sağlık Kurumları Yönetimi |
| Bölüm | Derlemeler |
| Yazarlar | |
| Yayımlanma Tarihi | 16 Ekim 2020 |
| Gönderilme Tarihi | 7 Şubat 2020 |
| Kabul Tarihi | 8 Haziran 2020 |
| Yayımlandığı Sayı | Yıl 2020 Cilt: 15 Sayı: 3 |
